(Q51297641)
Statements
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors. (English)
1 reference
Suzanne F Jones
1 reference
Lillian L Siu
1 reference
Johanna C Bendell
1 reference
James M Cleary
1 reference
Albiruni R A Razak
1 reference
Jeffrey R Infante
1 reference
Shuchi S Pandya
1 reference
Kristen J Pierce
1 reference
Brett Houk
1 reference
W Gregory Roberts
1 reference
S Martin Shreeve
1 reference
Geoffrey I Shapiro
1 reference
4 September 2015
1 reference
33
1 reference
5
1 reference
1100-1107
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference